Robert P. Ragusa - 01 Sep 2026 Form 4 Insider Report for Alamar Biosciences, Inc. (ALMR)

Reporting relationship: Director
Issuer ticker: ALMR
Reported as of: 01 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Sep 2026, 16:27:52 UTC
Prior SEC filing: 09 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Timothy White, Attorney-in-Fact

Key filing fact

Robert P. Ragusa filed Form 4 for Alamar Biosciences, Inc. (ALMR) on 03 Sep 2026.

Key facts

This page summarizes Robert P. Ragusa's Form 4 filing for Alamar Biosciences, Inc. (ALMR).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Sep 2026, 16:27.

Change

Previous filing in this sequence was filed on 09 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001222644 Primary reporting owner

RAGUSA ROBERT P

Relationship: Director
Address: C/O ALAMAR BIOSCIENCES, INC., 47071 BAYSIDE PARKWAY, FREMONT
Signature: /s/ Timothy White, Attorney-in-Fact
Signature date: 03 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALMR transaction

Common Stock

Award

Transaction value
Shares: +5,686
Change %
Price: $0.000000^*
Shares after: 5,686
Date: 01 Sep 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ALMR transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +25,599
Change %
Price: $0.000000^*
Shares after: 25,599
Date: 01 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 25,599
Exercise price: $29.36
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents a restricted stock unit ("RSU") award. The RSUs vest in equal annual installments over 3 years measured from September 1, 2026, subject to the reporting person's continuous service as of each such vesting date.

Footnote F2

One-third of the shares subject to the option will vest on September 1, 2027 and the remainder of the shares subject to the grant will vest in equal monthly installments thereafter through September 1, 2029, subject to the reporting person's continuous service as of each such vesting date.